Characterization and Transmission Dynamics of Carbapenemase-Encoding Genes in CREC

Carbapenem-resistant Enterobacter cloacae (CREC) is an important but comparatively less characterized component of the carbapenem-resistant Enterobacteriaceae problem. The reference study by Chen and colleagues examined isolates collected from eight teaching hospitals in Guangdong Province, China, during December 2022–June 2024. Rather than treating carbapenem resistance as a single phenotype, the investigators combined gene detection, genetic localization, antimicrobial susceptibility testing, conjugation, mobile-element analysis, and strain typing to reconstruct how resistance determinants may persist and spread. The complete study is available in BMC Microbiology.

Study Background and Research Question

The study was motivated by the possibility that the COVID-19 pandemic altered antibiotic exposure, hospital workflows, and opportunities for transmission. These pressures may favor the emergence and circulation of carbapenemase-encoding genes (CEGs), particularly when the genes reside on plasmids that can move between bacterial cells. In CREC, the distinction between chromosomal resistance, plasmid-borne resistance, and clonal spread is epidemiologically important: each mechanism implies a different intervention strategy.

The central research question was therefore not simply how frequently CEGs could be detected, but how they were organized and transmitted among CREC isolates from multiple hospitals. The authors asked which carbapenemase genes predominated, whether they were located on plasmids or chromosomes, whether they could transfer by conjugation, which mobile genetic elements accompanied them, and whether related isolates appeared in different clinical settings.

Key Innovation from the Reference Study

The study’s principal innovation is its integrated transmission framework. Plasmid elimination and PCR were used to infer the physical location of resistance genes; conjugation experiments tested whether those genes were transferable; and ERIC-PCR with NTSYS analysis assessed relatedness among isolates. This combination links molecular architecture to phenotype and epidemiology more effectively than gene detection alone.

That design also separates two forms of dissemination. Horizontal dissemination is supported experimentally when a resistance determinant transfers into a recipient strain. Vertical or clonal dissemination is inferred when highly related bacterial isolates share resistance characteristics across departments or hospitals. The distinction matters because a successful infection-control response may require both limiting plasmid exchange and interrupting transmission of a successful CREC lineage.

The work is also valuable because it examines gene location at a time when carbapenemase surveillance often reports only the presence or absence of a gene. A plasmid-associated blaNDM-1 signal has different implications from a chromosomal signal, even when both produce carbapenem resistance in routine testing.

Methods and Experimental Design Insights

The investigators analyzed 54 CREC isolates from eight teaching hospitals collected over the study period. The experimental sequence moved from screening to localization, phenotype, transfer, and population structure. This layered design is useful for researchers planning Gram-negative bacterial infection research because each assay answers a distinct biological question.

Protocol Parameters

• Isolate collection: The literature-backed cohort consisted of CREC recovered from eight teaching hospitals in Guangdong between December 2022 and June 2024; the study should be interpreted as a regional hospital surveillance snapshot rather than a population-wide prevalence survey.
• Gene detection and localization: Variable-temperature sodium dodecyl sulfate plasmid elimination was combined with PCR to distinguish plasmid-associated from chromosomal CEG signals. For replication, plasmid-loss controls and confirmation of bacterial viability are important because elimination-based localization is indirect.
• Susceptibility testing: Broth microdilution was used to compare resistance phenotypes across CEG-positive and CEG-negative groups. A laboratory follow-up should preserve standardized inoculum preparation, quality-control strains, and the same interpretive criteria across batches.
• Transferability: Plasmid conjugation followed by PCR tested whether detected CEGs could move into a recipient background. Transfer experiments should include donor-only, recipient-only, and transconjugant confirmation controls rather than relying on selective growth alone.
• Strain relatedness: ERIC-PCR and NTSYS software were used to classify the isolate collection into genotypes. Because fingerprinting has lower resolution than whole-genome sequencing, it is best used as an epidemiological screening layer followed by higher-resolution genomic analysis where resources permit.
• Mobile-element analysis: The study identified six mobile genetic element patterns and evaluated their association with CEG carriage. In a follow-up design, testing the same isolate for gene location, flanking elements, and plasmid backbone would strengthen causal interpretation.

The paper reports these parameters as part of its experimental design. The additional control recommendations above are workflow suggestions for reproducibility, not additional findings from the reference study.

Core Findings and Why They Matter

High CEG carriage and a dominant blaNDM-1 architecture

CEGs were detected in 46 of 54 isolates, or 85.19%. The dominant determinant was blaNDM-1. It was found on both chromosomes and plasmids in 18 isolates, representing 33.33% of the cohort, while 25 isolates, or 46.30%, carried blaNDM-1 exclusively on plasmids. A smaller subset carried plasmid-associated blaIMP alone, and one isolate contained both plasmid-borne blaNDM-1 and blaKPC-2. These findings emphasize that blaNDM-1 was not confined to a single genetic compartment.

The plasmid-dominant pattern is especially consequential. Plasmids can move between compatible bacterial hosts, allowing resistance to spread even when the original bacterial clone is not transmitted. Conversely, detection on both plasmids and chromosomes suggests that resistance may be stabilized through more than one genetic route. The authors therefore provide a stronger mechanistic explanation for persistence than a survey based only on carbapenem susceptibility.

CEG carriage tracked with broader multidrug resistance

Using broth microdilution, the CEG-positive group showed significantly higher resistance rates to imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin than the CEG-negative group, with reported differences meeting P<0.05. The result does not mean that every resistance phenotype was caused by the detected carbapenemase gene. Instead, it indicates that CEG-positive isolates were embedded in a broader multidrug-resistant background, potentially involving additional plasmid genes, permeability changes, efflux, or other chromosomal mechanisms.

Conjugation demonstrated substantial horizontal-transfer potential

Conjugation and PCR confirmed transfer of CEGs in 44 of 46 CEG-positive isolates, a 95.65% success rate. Transfer was observed for blaNDM-1 in 42 of 44 tested cases and for blaIMP in both tested cases, whereas the single blaKPC-2-associated isolate did not yield a successful transfer event. These results support the concern that plasmid-associated CEGs can disseminate efficiently under suitable laboratory conditions.

However, conjugation success is a capability assay, not direct proof of transmission between patients. Its significance is that it identifies isolates and genetic contexts that merit infection-control attention, plasmid sequencing, and environmental or contact investigations.

Mobile elements and clonal patterns connected local and inter-hospital spread

The study identified six mobile genetic element types, with ISEcp1 being the most prevalent, detected in 47 of 54 isolates, or 87.04%. Isolates carrying four mobile-element types simultaneously formed the largest pattern, accounting for 22 of 54 isolates, or 40.74%. This supports a genomic environment in which resistance genes may be mobilized, rearranged, or maintained alongside other adaptive determinants.

ERIC-PCR and NTSYS grouped the collection into 17 genotypes. Types E and G were each found in 11 of 54 isolates, or 20.37%, and occurred in departments across five hospitals. Two type E isolates shared a Dice coefficient of 100%, providing a particularly close fingerprint match. The epidemiological distribution was highest among male patients, older patients, respiratory-medicine cases, and sputum specimens, reported as 64.81%, 72.22%, 20.37%, and 33.33%, respectively. These are descriptive distributions, not proof that sex, age, department, or specimen type independently caused CEG acquisition.

Comparison with Existing Internal Articles

The internal mechanism-focused resource examines membrane disruption and immune-signaling questions, whereas the reference study is centered on resistance genetics and hospital transmission. The relationship is complementary: the BMC Microbiology paper identifies the organisms and resistance architectures that define an infection setting, while mechanistic assays address how an intervention affects bacterial or host-cell biology. Neither scope should be used as a substitute for the other.

A separate workflow-oriented resource discusses experimental applications in Gram-negative infection and sepsis-model research. Its practical emphasis can help frame follow-up experiments, but the reference study itself did not test treatment efficacy, host survival, or immune modulation. The most defensible connection is therefore methodological: use the study’s isolate characterization and transfer assays to define the bacterial context before extending into intervention or host-response models.

Limitations and Transferability

Several limitations constrain generalization. The sample came from teaching hospitals in one province, so the observed gene distribution may not represent other regions, community settings, or non-teaching hospitals. The collection also covered a defined period during and after major pandemic-related disruptions; without a directly matched pre-pandemic cohort, the study cannot quantify how the pandemic itself changed transmission dynamics.

Plasmid elimination provides useful localization evidence but does not replace complete plasmid sequencing. Similarly, ERIC-PCR can reveal clusters but cannot resolve transmission direction or distinguish highly related plasmids with the precision of whole-genome sequencing. Conjugation experiments show potential transfer under laboratory selection, not the frequency of transfer in patients. Finally, higher resistance rates in the CEG-positive group establish association rather than a complete causal model, because co-carried resistance determinants and host-adaptation mechanisms were not exhaustively resolved in the summarized design.

Despite these constraints, the framework is transferable to other CRE surveillance programs. The most useful adaptation would retain the sequence of gene screening, genetic localization, susceptibility testing, transfer assessment, and strain relatedness, while adding longitudinal sampling, clinical metadata, plasmid sequencing, and environmental isolates.

Research Support Resources

Why this cross-domain matters, maturity, and limitations

The bridge from carbapenemase surveillance to intervention research is useful because resistance architecture determines the bacterial context in which an antimicrobial or host-response assay is interpreted. It remains indirect and relatively early: the reference study did not evaluate Polymyxin B, polymyxin sulfate, treatment combinations, or a dendritic cell maturation assay. Accordingly, its results should not be presented as evidence of activity, synergy, or immune benefit for any particular compound.

For related susceptibility experiments and Gram-negative bacterial infection research, researchers can use Polymyxin B (sulfate) (SKU C3090) to support similar workflows, with dosing and controls established independently for the organism and assay. Separate sepsis and bacteremia models may address in vivo questions, while a dendritic cell maturation assay examines host-cell responses rather than gene transfer. Its description as an antibiotic for bloodstream and urinary tract infections should likewise not be conflated with the clinical outcomes measured in this CREC surveillance study.